King Luther Capital Management Corp lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 4,504 shares of the exchange traded fund’s stock after selling 130 shares during the period. King Luther Capital Management Corp’s holdings in SPDR S&P Biotech ETF were worth $445,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Tidemark LLC raised its holdings in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at about $40,000. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth about $40,000. ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $44,000. Finally, Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $49,000.
SPDR S&P Biotech ETF Price Performance
XBI opened at $96.24 on Friday. SPDR S&P Biotech ETF has a one year low of $71.99 and a one year high of $105.47. The business has a 50 day simple moving average of $98.44 and a two-hundred day simple moving average of $96.27. The firm has a market capitalization of $7.34 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Conference Calls and Individual Investors
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- MarketBeat Week in Review – 11/18 – 11/22
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.